Literature DB >> 8675290

In vitro simulation of immunosuppression caused by Trypanosoma brucei: active involvement of gamma interferon and tumor necrosis factor in the pathway of suppression.

A Darji1, A Beschin, M Sileghem, H Heremans, L Brys, P De Baetselier.   

Abstract

Experimental infections of mice with the African trypanosome Trypanosoma brucei lead to a profound state of T-cell unresponsiveness in the lymph node cell (LNC) compartment. This suppression is mediated by macrophage-like cells which inhibit interleukin 2 (IL-2) secretion and down-regulate IL-2 receptor expression (M. Sileghem, A. Darji, R. Hamers, M. Van de Winkel, and P. De Baetselier, Eur. J. Immunol. 19:829-835, 1989). Similar suppressive cells can be generated in vitro by pulsing 2C11-12 macrophage hybridoma cells with opsonized T. brucei parasites (2C11-12P cells). Cocultures of 2C11-12P cells and LNCs secrete higher levels of gamma interferon (IFN-gamma), and the hyperproduction of IFN-gamma was found to be confined to CD8+ lymphoid cells. Elimination of CD8+ cells from cocultures of 2C11-12P cells and LNCs restores the T-cell proliferative response. Furthermore, addition of neutralizing anti-IFN-gamma antibodies to the cocultures reduces the level of suppression and concomitantly restores the level of IL-2 receptor expression. Hence, IFN-gamma plays a cardinal role in this in vitro model for T. brucei-elicited immunosuppression. Cocultures of LNCs and 2C11-12P cells in a two-chamber culture system further demonstrated that cell-cell contact is required for hyperproduction of IFN-gamma and, moreover, that IFN-gamma cooperates with a 2C11-12P-derived diffusible factor to exert its suppressive activity. Finally, tumor necrosis factor alpha (TNF-alpha produced by 2C11-12P cells was found to be implicated in the hyperproduction of IFN-gamma, since addition of neutralizing anti-TNF-alpha antibodies to cocultures reduced the level of suppression and concomitantly abrogated the hyperproduction of IFN-gamma. Collectively, our findings indicate that T. brucei-elicited suppressive 2C11-12 macrophage cells differentially influence T-cell subpopulations: (i) CD8+ cells are signaled via cell-cell contact to produce IFN-gamma, and TNF-alpha is implicated in this process, and (ii) locally produced IFN-gamma and macrophage-released factors act in concert to inhibit CD4+ and CD8+ T-cell proliferative responses.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8675290      PMCID: PMC174019          DOI: 10.1128/iai.64.6.1937-1943.1996

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  34 in total

1.  Regulation by interferons of the local inflammatory response to bacterial lipopolysaccharide.

Authors:  H Heremans; R Dijkmans; H Sobis; F Vandekerckhove; A Billiau
Journal:  J Immunol       Date:  1987-06-15       Impact factor: 5.422

2.  Experimental Trypanosoma brucei infections selectively suppress both interleukin 2 production and interleukin 2 receptor expression.

Authors:  M Sileghem; R Hamers; P De Baetselier
Journal:  Eur J Immunol       Date:  1987-10       Impact factor: 5.532

3.  Anti-proliferative effect of IFN-gamma in immune regulation. I. IFN-gamma inhibits the proliferation of Th2 but not Th1 murine helper T lymphocyte clones.

Authors:  T F Gajewski; F W Fitch
Journal:  J Immunol       Date:  1988-06-15       Impact factor: 5.422

4.  Different mechanisms account for the suppression of interleukin 2 production and the suppression of interleukin 2 receptor expression in Trypanosoma brucei-infected mice.

Authors:  M Sileghem; A Darji; L Remels; R Hamers; P De Baetselier
Journal:  Eur J Immunol       Date:  1989-01       Impact factor: 5.532

5.  Murine tumour necrosis factor plays a protective role during the initial phase of the experimental infection with Trypanosoma brucei brucei.

Authors:  S Magez; R Lucas; A Darji; E B Songa; R Hamers; P De Baetselier
Journal:  Parasite Immunol       Date:  1993-11       Impact factor: 2.280

6.  A T cell activity that enhances polyclonal IgE production and its inhibition by interferon-gamma.

Authors:  R L Coffman; J Carty
Journal:  J Immunol       Date:  1986-02-01       Impact factor: 5.422

7.  Recombinant interferon-gamma inhibits the B cell proliferative response stimulated by soluble but not by Sepharose-bound anti-immunoglobulin antibody.

Authors:  J J Mond; F D Finkelman; C Sarma; J Ohara; S Serrate
Journal:  J Immunol       Date:  1985-10       Impact factor: 5.422

8.  Inhibition of macrophage-induced antigen-specific T-cell proliferation by interferon-gamma.

Authors:  L N McKernan; K J Blank; G L Spitalny; D M Murasko
Journal:  Cell Immunol       Date:  1988-07       Impact factor: 4.868

9.  Dual role of macrophages in the suppression of interleukin 2 production and interleukin 2 receptor expression in trypanosome-infected mice.

Authors:  M Sileghem; A Darji; R Hamers; M Van de Winkel; P De Baetselier
Journal:  Eur J Immunol       Date:  1989-05       Impact factor: 5.532

10.  Anti-proliferative effect of IFN-gamma in immune regulation. II. IFN-gamma inhibits the proliferation of murine bone marrow cells stimulated with IL-3, IL-4, or granulocyte-macrophage colony-stimulating factor.

Authors:  T F Gajewski; E Goldwasser; F W Fitch
Journal:  J Immunol       Date:  1988-10-15       Impact factor: 5.422

View more
  19 in total

Review 1.  Host-parasite interactions in trypanosomiasis: on the way to an antidisease strategy.

Authors:  Nicolas Antoine-Moussiaux; Philippe Büscher; Daniel Desmecht
Journal:  Infect Immun       Date:  2009-01-21       Impact factor: 3.441

2.  Immunobiology of African trypanosomes: need of alternative interventions.

Authors:  Toya Nath Baral
Journal:  J Biomed Biotechnol       Date:  2010-02-23

3.  Bacterial lipoprotein-based vaccines induce tumor necrosis factor-dependent type 1 protective immunity against Leishmania major.

Authors:  Javier Cote-Sierra; Amin Bredan; Carmen M Toldos; Benoit Stijlemans; Lea Brys; Pierre Cornelis; Manuel Segovia; Patrick de Baetselier; Hilde Revets
Journal:  Infect Immun       Date:  2002-01       Impact factor: 3.441

4.  Tumor necrosis factor alpha is a key mediator in the regulation of experimental Trypanosoma brucei infections.

Authors:  S Magez; M Radwanska; A Beschin; K Sekikawa; P De Baetselier
Journal:  Infect Immun       Date:  1999-06       Impact factor: 3.441

5.  The Trypanosoma brucei gambiense secretome impairs lipopolysaccharide-induced maturation, cytokine production, and allostimulatory capacity of dendritic cells.

Authors:  Edwin Garzón; Philippe Holzmuller; Rachel Bras-Gonçalves; Philippe Vincendeau; Gérard Cuny; Jean Loup Lemesre; Anne Geiger
Journal:  Infect Immun       Date:  2013-06-24       Impact factor: 3.441

6.  Interleukin-4-dependent immunoglobulin G1 isotype switch in the presence of a polarized antigen-specific Th1-cell response to the trypanosome variant surface glycoprotein.

Authors:  L R Schopf; H Filutowicz; X J Bi; J M Mansfield
Journal:  Infect Immun       Date:  1998-02       Impact factor: 3.441

7.  Tsetse fly saliva accelerates the onset of Trypanosoma brucei infection in a mouse model associated with a reduced host inflammatory response.

Authors:  Guy Caljon; Jan Van Den Abbeele; Benoît Stijlemans; Marc Coosemans; Patrick De Baetselier; Stefan Magez
Journal:  Infect Immun       Date:  2006-09-05       Impact factor: 3.441

8.  Recombinant tumor necrosis factor alpha does not inhibit the growth of African trypanosomes in axenic cultures.

Authors:  Hiroshi Kitani; Samuel J Black; Yoshio Nakamura; Jan Naessens; Noel B Murphy; Yuichi Yokomizo; John Gibson; Fuad Iraqi
Journal:  Infect Immun       Date:  2002-04       Impact factor: 3.441

9.  Proinflammatory cytokine expression in the early phase of Trypanosoma brucei rhodesiense infection in vervet monkeys (Cercopithecus aethiops).

Authors:  Naomi Maina; Joseph Maina Ngotho; Tom Were; John Kibuthu Thuita; David Mumo Mwangangi; John Maina Kagira; Joseph Mathu Ndung'u; Jeremy Sternberg
Journal:  Infect Immun       Date:  2004-05       Impact factor: 3.441

10.  Killing of trypanosomatid parasites by a modified bovine host defense peptide, BMAP-18.

Authors:  Lee R Haines; Jamie M Thomas; Angela M Jackson; Brett A Eyford; Morteza Razavi; Cristalle N Watson; Brent Gowen; Robert E W Hancock; Terry W Pearson
Journal:  PLoS Negl Trop Dis       Date:  2009-02-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.